Find Academic Supervisors

Anders EnocsonView profile

Adjunct Professor

• Orthopedic Traumatology
• Clinical Epidemiology
• Trauma Surgery
• +7 more

Anders Enocson is an Adjunct Professor of Orthopedic Traumatology at the Karolinska Institutet , leading the Orthopedics Research Group at the Department of Molecular Medicine and Surgery. He combines academic research with clinical practice as a senior physician at Karolinska University Hospital. Specialist in orthopedic surgery since 2007 First professor in orthopedic traumatology in Sweden (2020) Extensive clinical experience across Sweden and UK Research focus: Trauma epidemiology, fracture outcomes, and AI applications His research spans: Trauma Registry Karolinska - Data-driven quality improvement SweTrau - National trauma registry machine learning models Pelvic Fractures - Complication reduction strategies Tendon Repair - Mechanobiology and neuropeptide regulation Medical Imaging - CT motion analysis for fractures Orthopedic Oncology - Sarcoma treatment outcomes Key publication trends show emphasis on Machine learning for mortality prediction 3D CT analysis in fracture follow-up Long-term joint replacement outcomes Postoperative complication risk factors Tendon healing biomarkers Clinical collaborations include AO Foundation courses in Sweden Karolinska Traumacentrum leadership International orthopedic networks Multidisciplinary teams in trauma care

• Autoimmunity
• Rheumatology
• Immunology
• +5 more

Marie Wahren-Herlenius is Professor of Experimental Rheumatology at Karolinska Institutet and Head of Department at the Department of Medicine, Solna since 2021. She leads the Autoimmunity and Cancer research group focusing on immune system function in autoimmune diseases and cancer. With extensive international experience from the University of Bergen, University of Tokyo, and Harvard Medical School, she has established herself as a leading researcher in rheumatology. Her research interests center on autoimmune rheumatic diseases, particularly Sjögren's syndrome, congenital heart block, and the role of interferons in autoimmune conditions and cancer. She investigates why women are disproportionately affected by rheumatic diseases, with nine out of ten Sjögren's syndrome patients being women. Her work spans experimental studies at cellular and molecular levels, experimental models, and clinical patient-based research. Analysis of her recent publications reveals a strong focus on genetic factors in autoimmune diseases, particularly HLA associations and polygenic risk scores. Her research consistently explores sex differences in autoimmune conditions and the molecular mechanisms behind autoantibody production. The work bridges basic immunology with clinical applications, particularly in understanding disease pathogenesis to develop better diagnostics and treatments. Göran Gustafsson Prize in Medicine Nanna Svartz Prize for Rheumatological Research Scandinavian Journal of Rheumatology's Prize for Rheumatological Research IMID Prize for Research on Immune-Mediated Inflammatory Diseases Three nominations for best abstract by Swedish Rheumatological Society Three doctoral theses from her group nominated for best rheumatology thesis Professor Wahren-Herlenius has chaired the Scandinavian Immunology Society (2010-2015), Junior Faculty at Karolinska Institutet (2002-2005), and the Doctoral Student Association (1991). Her research group comprises approximately 15 people with both clinical and basic science backgrounds. She has received significant research funding supporting studies on autoimmune mechanisms, with particular emphasis on understanding the cellular and molecular basis of disease processes to develop prevention strategies, new diagnostics, and treatments. Her laboratory investigates the function of interferon-regulated genes in autoimmune diseases and cancer using various techniques including lentiviral CRISPR/Cas9, shRNA, and experimental models. The group also uses genome-wide CRISPR/Cas9 libraries in cancer cells to identify genes involved in metastasis and drug response.

Peter CavnarView profile

Associate Professor

• Cell Biology
• Molecular Biology
• Immunology
• +14 more

Peter Cavnar is an Associate Professor in the Department of Biology at the University of West Florida, affiliated with the Hal Marcus College of Science and Engineering. He serves as the Interim Chair of the Physics Department and Associate Dean of HMCSE. His academic and research work is centered on cell biology, immunology, and molecular mechanisms of disease. Ph.D. in Biological Sciences – Cell & Molecular Biology, Florida State University B.S. in Biological Sciences, Florida State University Postdoctoral Training, Department of Medical Microbiology and Immunology, University of Wisconsin–Madison Dr. Cavnar's research focuses on fundamental cellular processes such as cell motility, adhesion, cytoskeletal dynamics, and cell death , with direct relevance to immunological diseases like severe congenital neutropenia (SCN) and inflammatory disorders including arthritis and lupus. He investigates how defects in proteins like HAX1 disrupt neutrophil function, using the PLB-985 cell line as a model. Additionally, he explores the evolutionary origins of wound healing and regeneration through studies on marine organisms, particularly comb jellies (Ctenophores). His recent publications span journals such as the Journal of Biological Chemistry and Biomedical Microdevices , reflecting interdisciplinary work combining cell biology, bioengineering, and immunology. Key themes across his research include neutrophil migration, microfluidic platforms for cell assays, actin regulation, and antibody validation . This body of work highlights a strong emphasis on both basic science and translational applications. Dr. Cavnar has co-authored a patent utilizing microfluidics for cell biology studies, underscoring innovation in experimental methodology. While no formal scientific awards are listed, his leadership roles and sustained research output indicate significant scholarly impact. He teaches courses including Cell Biology, Biochemistry, General Biology, and Zoology, contributing extensively to undergraduate and graduate education. He advises students and mentors research, though specific advisees are not named. His lab engages in collaborative science, often working with interdisciplinary teams involving bioengineers and immunologists. Current projects involve developing novel model systems and refining tools for studying immune cell behavior in controlled environments.

• Breast Cancer Research
• Biobanking
• Cancer Microenvironment
• +3 more

Louise L. Jones serves as the Director of the NRP Biorepository at the University of East Anglia, where she is a member of the Faculty of Medicine and Health Sciences with focus on Metabolic Health research. Her leadership role in biorepository management positions her at the intersection of clinical practice and research infrastructure. Her research program centers on breast cancer pathology with particular emphasis on: Inflammatory breast cancer and immune microenvironment characterization DCIS progression mechanisms and myoepithelial cell biology Advanced imaging techniques for surgical margin detection Biobanking practices and ethical considerations in tissue sample management Dr. Jones's work demonstrates a strong translational focus, bridging basic science discoveries with clinical applications in breast cancer diagnosis and treatment. Her publications reveal a consistent trajectory of investigating cellular mechanisms that drive cancer progression while developing practical diagnostic methodologies. Her scientific contributions have received significant attention, with multiple publications accumulating substantial citations. Notably, her 2021 work on X-ray phase-contrast computed tomography has been referenced in patents and Wikipedia pages, indicating substantial impact on the field of breast cancer diagnostics. As Director of the NRP Biorepository, she oversees critical research infrastructure that supports numerous clinical and translational studies, particularly in the metabolic health domain. Her leadership ensures high-quality biological specimens are available for cutting-edge cancer research while navigating complex ethical and logistical challenges inherent in biobanking operations.

Frans BianchiView profile

Assistant Professor

• Membrane Proteins
• Lipid Antigens
• T Cell Activation
• +4 more

Frans Bianchi is an Assistant Professor at the University of Groningen's Faculty of Science and Engineering, affiliated with the Molecular Immunology group within the Groningen Biomolecular Sciences and Biotechnology Institute (GBB). His research focuses on membrane proteins and lipids as antigens in T cell activation and their application in vaccination strategies. Bianchi holds a PhD in Membrane Enzymology from the University of Groningen (2016) and advanced degrees in Molecular Biology and Chemistry. Research Interests: Antigen presentation mechanisms T cell receptor interactions with MHC complexes Role of lipids in immune responses Development of immunotherapeutic agents Short-chain fatty acid effects on immune cells Recent Research Themes: Recent publications highlight work on antigen processing dynamics, macrophage inflammatory responses, and diagnostic methods for cell proliferation. Notable findings include butyrate's dual inflammatory effects and novel insights into CD36 receptor function in cancer biology. His teams explore both basic immunological mechanisms and translational applications. Awards & Grants: Recipient of NWO-VENI, ZonMW Off-Road grants, and Comenius Teaching Fellowships. Collaborates on NWO Demonstrator projects for cancer cell detection technologies. Labs & Teams: Leads the Molecular Immunology group focusing on immune cell signaling and vaccine development. Collaborates with multidisciplinary teams including organic chemists and biomedical engineers.

Yvonne GarbersView profile

Professor

• Organizational Psychology
• Leadership
• Human Resource Management
• +10 more

Prof. Dr. Yvonne Garbers is a Professor of Organizational Psychology at the Institute for Communication Management , Osnabrück University of Applied Sciences, Lingen Campus. Her research focuses on organizational leadership, team dynamics, and the interplay of virtuality and diversity in workplaces. She also teaches Human Resource Management, Organizational Communication, and Applied Statistics. Education: PhD in Psychology (summa cum laude), Christian-Albrechts-Universität zu Kiel; Diplom in Psychology (grade: "Sehr gut"), CAU Kiel. Research Trends: Recent publications explore cytokine signaling in osteoarthritis, justice repair dynamics, and health impacts of workplace innovations like sit-stand desks. Her work bridges molecular biology and organizational psychology, emphasizing interdisciplinary applications. Labs & Projects: Involved in the Mittelstand-Digitalzentrum Lingen.Münster.Osnabrück and the Labor für Organisationspsychologie (Interaction & Communication section), focusing on adaptability and leadership models. Teaching: Courses include Organizational Psychology, Human Resource Management, Communication in HR, Introduction to General Psychology, and Workshops on Change and Resilience. Her contact details: Office Hours by appointment, Room KB304, Phone: 0591-80098-435, Email: y.garbers@hs-osnabrueck.de . She is married with two daughters (born 2014 and 2016).

Wuqaas M. MunirView profile

Professor

• Ophthalmology
• Corneal Transplantation
• Cataract Surgery
• +4 more

Wuqaas M. Munir, MD, is a Professor in the Department of Ophthalmology and Visual Sciences at the University of Maryland School of Medicine. He holds multiple leadership positions including Chief of Ophthalmology at the Baltimore VA Medical Center, Director of the Refractive Surgery Service, and Cornea Fellowship Director. Previously, he served as Assistant Professor and Cornea Service Director at Boston University School of Medicine for eight years. Education: B.S.E., University of Pennsylvania (Summa Cum Laude, 1997) M.D., University of Pittsburgh School of Medicine (2001) Residency in Ophthalmology, University of Illinois at Chicago (2002-2005) Fellowship in Cornea/Refractive Surgery, Bascom Palmer Eye Institute (2005-2006) Research Focus: Dr. Munir specializes in corneal transplantation (DMEK/DSEK), complex cataract surgery, refractive surgery (LASIK), and ocular imaging. His work integrates artificial intelligence for keratoconus detection, sociomedical factors in eye banking, and surgical outcomes research. He maintains strong interests in medical education as Associate Residency Program Director. Publication Trends (2024-2025): Recent articles demonstrate significant emphasis on AI applications in corneal disease diagnostics, health disparities in diabetic eye care, computational analysis of real-world ophthalmic datasets, and pharmacological safety profiles of glaucoma medications. Machine learning approaches feature prominently across his latest research. Clinical & Training Roles: As Cornea Fellowship Director and Residency Program Associate Director, Dr. Munir oversees surgical training programs. He maintains active clinical practice in advanced cataract and corneal surgeries at the University of Maryland Medical System and Baltimore VA.

Franziska LabrenzView profile

Researcher

• Interoceptive Sensations
• Visceral Pain
• Gut-Brain Interaction
• +5 more

Dr. Franziska Labrenz is a researcher at the Department of Medical Psychology and Medical Sociology within the Faculty of Medicine at Ruhr University Bochum. Her work focuses on the complex mechanisms of visceral pain and its modulation by psychological and social factors. Department: Medical Psychology and Medical Sociology Academic Rank: Researcher Key Collaborators: Prof. Elsenbruch, Dr. Icenhour, Prof. Benson Research Interests : Dr. Labrenz investigates interoceptive sensations, particularly chronic visceral pain, through behavioral experiments and neuroimaging studies. Her research explores how stress, anxiety, attention, and learning/memory processes influence pain perception, with a focus on gut-brain interactions and neurovascular responses during inflammation. Publication Trends : Her recent work (2023-2015) spans visceral pain neuroimaging, inflammation-related anxiety, fear conditioning models, and sex-based differences in pain processing. Key methodologies include fMRI, functional connectivity analysis, and experimental endotoxemia. Core Themes : Visceral Pain Mechanisms Neuroimaging & Functional Connectivity Stress-Anxiety-Pain Interactions Gut-Brain Axis Sex Differences Conditioning & Extinction Processes

• Autoimmunity
• Immunology
• Arthritis
• +7 more

Kamal D. Moudgil is a Professor in the Department of Microbiology and Immunology at the University of Maryland School of Medicine, with a secondary appointment in the Division of Rheumatology, Department of Medicine. Over two decades, he has led research in autoimmunity and immune regulation using rat models of rheumatoid arthritis (adjuvant arthritis) and multiple sclerosis (EAE). Focus on cellular and molecular pathways in autoimmunity Development of targeted drug delivery systems Investigation of natural products and biomarkers (e.g., miRNAs) His work explores immune cell interactions, including T cells, B cells, macrophages, and stromal cells like fibroblasts and osteoclasts. Funded by NIH (R01, P01, R21, R03), VA Merit, Arthritis Foundation, and Rheumatology Research Foundation. Research trends from his publications highlight: Natural products (celastrol, pristimerin) for autoimmune therapy Peptide-guided drug delivery systems Microbiome-derived metabolites in immune modulation Role of heat-shock proteins in pathogenesis and tolerance Th17/Treg balance and cytokine networks in disease

Gary BrennanView profile

Assistant Professor

• Epigenetics
• RNA Biology
• Epilepsy
• +2 more

Dr. Gary Brennan is an Assistant Professor at the School of Biomolecular and Biomedical Science, University College Dublin, and a member of the Conway Institute. He is a Funded Investigator at the FutureNeuro Research Center and has held affiliations with institutions including the Royal College of Surgeons in Ireland (RCSI) and the University of California-Irvine. His research focuses on the molecular mechanisms of epilepsy, particularly epigenetic and epitranscriptomic regulation, RNA modifications, and neuroinflammatory pathways. Education: PhD in Physiology & Medical Physics from RCSI (2015) Postdoctoral Training: University of California-Irvine (2012-2015) under Prof. Tallie Z. Baram; RCSI (2016-2018) under Prof. David Henshall His research program addresses three critical challenges: (1) understanding molecular reprogramming after brain insults, (2) developing RNA-based therapies targeting epigenetic processes, and (3) identifying peripheral biomarkers for epilepsy prediction. Key contributions include studies on microRNA regulation of seizure networks, m6A RNA methylation in temporal lobe epilepsy, and systemic delivery of antagomirs timed with blood-brain barrier disruption. His work has been published in journals like Nature Reviews Neurology , JCI Insight , and Molecular Brain . Recent funding includes grants from Science Foundation Ireland (SFI), Health Research Board (HRB), and the European Union. He has received awards such as the CURE Taking Flight Award and Marie Curie Fellowship. Dr. Brennan also supervises PhD students and coordinates modules on CNS diseases and multicellular systems.

• Cancer Biology
• Hematopoietic Malignancies
• Extracellular Vesicles
• +6 more

Margaret McGee is an Associate Professor at the School of Biomolecular and Biomedical Science , University College Dublin , with a research focus on cancer biology and extracellular vesicle signaling. Her work spans hematological malignancies, bone marrow microenvironment interactions, and mitotic regulatory mechanisms. She coordinates major modules including Genetic Basis of Disease and Regulation of Gene Expression . BSc University of Reading Dip Applied Science Dublin Institute of Technology PhD Biochemistry Trinity College Dublin Her research explores extracellular vesicle-mediated communication in cancer progression, cyclophilin A's role in mitotic exit, and preclinical biotherapeutic development. Current collaborations with Vejle Hospital Denmark and Mater Hospital Dublin investigate EV-based liquid biopsies for therapy response prediction. Notably, she co-authored the foundational MISEV2023 guidelines for extracellular vesicle research. Scientific contributions include: Wellcome Trust ISSF Mid Career Fellow (2017) Conway Institute Fellow (2007) IRCSET Fellowship (2003) She leads the EU Twinflag consortium for EV-based biomarker development in joint disorders and chairs the SBBS Research, Innovation and Impact Committee (2020-2024). Her lab has trained numerous researchers who now hold prominent positions in academia and industry.

Steven M. YellonView profile

Professor

• Reproductive Physiology
• Cervical Remodeling
• Preterm Birth Mechanisms
• +3 more

Steven M. Yellon is a Professor in both the Physiology Division of Basic Sciences and the Department of Gynecology and Obstetrics at Loma Linda University School of Medicine. His research focuses on the physiological mechanisms underlying pregnancy, parturition, and preterm birth, with particular emphasis on cervical remodeling processes and neural regulation of birth. Dr. Yellon's educational background includes: PhD from University of Michigan Ann Arbor (1985) MA from University of Connecticut (1981) BA from University of Kansas (1977) Bachelor of Arts from Hartwick College (1974) Dr. Yellon's research primarily investigates the complex interplay between neural, endocrine, and immune factors in cervical remodeling during pregnancy and parturition. His work has established critical connections between vagus nerve signaling, macrophage activity, and progesterone regulation in the processes leading to both term and preterm birth. Through innovative approaches using murine models, he has made significant contributions to understanding how inflammation triggers preterm labor and how potential interventions might prevent it. Analysis of Dr. Yellon's recent publications (2020-2025) reveals a strong focus on translational approaches to prevent preterm birth, with particular attention to nanoformulation drug delivery systems, macrophage phenotypes in cervical tissue, and the role of N,N-dimethylacetamide as a potential therapeutic agent. His work increasingly integrates advanced imaging techniques with molecular analyses to provide comprehensive understanding of cervical remodeling processes. Dr. Yellon has secured significant research funding through multiple NIH grants as Principal Investigator, including projects focused on: Prevention of Inflammation Driven Cervix Remodeling and Preterm Birth (2020-2022) Neural Regulation of Prepartum Cervical Ripening (2011-2017) Vagus nerve stimulation modulating neuroinflammation (2018-2020) Dr. Yellon maintains an active laboratory investigating the immunological, neural, and hormonal regulation of cervical ripening and parturition. His team employs a multidisciplinary approach combining molecular biology, histology, imaging techniques, and physiological measurements in both murine and human tissue models to advance understanding of the complex processes leading to birth.

Yağmur Nil DoğanView profile

Associate Professor

• Veterinary Food Hygiene
• Microbiology
• Food Safety
• +3 more

Dr. Yağmur Nil Doğan is an Associate Professor at Gaziantep University, İslahiye Vocational School, Veterinary Medicine Department . She holds an ORCID iD and is affiliated with YÖK (Turkish Council of Higher Education). PhD in Veterinary Food Hygiene and Technology (2016, Afyon Kocatepe University) BSc in Veterinary Medicine (2010, Selçuk University) Her research focuses on food safety , microbial quality of animal products , biogenic amines , and public health risks in food systems . She investigates the role of Lactic Acid Bacteria in fermented foods and the impact of toxins like aflatoxins and antibiotics in milk and fish. Recent publications highlight seasonal variations in aflatoxin levels , antibiotic resistance in Enterococcus , and microbial interactions in dairy farms . She has contributed to understanding oxidative stress markers in buffalo milk and probiotic effects on poultry . She has led projects on lactic acid bacteria in fermented foods, antibiotic residues in aquaculture, and starter cultures for meat preservation. Her role as Department Head (2021-2028) reflects leadership in veterinary education. Teaching includes Hygiene and Sanitation , General Microbiology , and Veterinary Public Health at both undergraduate and graduate levels. She has international research experience at University of Naples Federico II (2024) and industry exposure at Pınar Entegre Et ve Un Sanayii A.Ş. (2009).

Sinduja SubramanianView profile

Research Fellow

• Neurodegenerative Diseases
• Neuroimmunology
• Vascular Biology
• +4 more

Sinduja Subramanian is a Research Fellow at the Centre for Motor Neuron Disease Research within Macquarie Medical School, Macquarie University. Her work bridges vascular biology and neuroimmunology, focusing on immune dysregulation mechanisms in neurodegenerative diseases. She previously completed her PhD in Macquarie Neurosurgery (2015-2018) developing pro-thrombotic treatments for brain arteriovenous malformations. Educational Background: PhD in Neurosurgery (Macquarie University, 2018) Current Role: Research Fellow in Motor Neuron Disease Research Her research explores: Vascular targeting agents for neurological conditions Immune-inflammatory processes in motor neuron disease Radiation-induced endothelial surface modifications Thrombotic treatment strategies for vascular malformations Key publication trends include: Development of vascular targeting therapies through αB-crystallin and CD166 research Investigation of inflammatory mediators in neurodegenerative disease progression Application of pulsatile flow models to thrombus formation studies Integration of molecular imaging and proteomics techniques Translational focus from animal models to clinical applications Peer-reviewed contributions across Thrombosis Research, International Journal of Molecular Sciences, and Translational Stroke Research Contact: sinduja.subramanian@mq.edu.au

Eddy Sotelo PérezView profile

Professor

• Medicinal Chemistry
• GPCR Pharmacology
• Drug Discovery
• +5 more

Eddy Sotelo Pérez is a Full Professor of Medicinal Chemistry at the Faculty of Pharmacy, University of Santiago de Compostela, where he leads the Sotelo Research Group (ComBioMed) within the Center for Research in Biological Chemistry and Molecular Materials (CIQUS). He holds appointments in both the Department of Organic Chemistry and the Institute of Industrial Pharmacy, directing a multidisciplinary team focused on drug discovery and development. Full Professor of Medicinal Chemistry (since April 2023) Associate Editor, Purinergic Signalling (since 2022) Principal Investigator, ComBioMed Research Group Co-founder, Celtarys Research His research spans medicinal chemistry, chemical biology, and catalysis, with particular emphasis on GPCR pharmacology for cancer immunotherapy, neurological disorders, and inflammatory diseases. The group pioneers multicomponent synthetic strategies and 3D-printed catalytic systems to accelerate drug discovery while reducing environmental impact. Analysis of recent publications reveals a strong focus on GPCR-targeted therapeutics, particularly CB2 and A2B receptors for cancer and inflammation. The group has successfully translated fluorescent probe technology to industry through Celtarys Research, eliminating radioactive compounds in drug screening. Recent work integrates 3D printing with heterogeneous catalysis to develop sustainable pharmaceutical manufacturing processes. Fernando Calvet Prats award from Royal Galician Academy of Sciences (2022) Celtarys Research finalist in Royal Society of Chemistry Emerging Technologies Competition Multiple patents on catalytic systems and fluorescent probes Sotelo actively mentors doctoral students across multiple projects including CAPN12-IO (calpain-12 inhibitors for cancer immunotherapy) and PREDICTEAM (immune checkpoint analysis). His research has secured significant funding from MCIN, AEI, EU NextGeneration, and Xunta de Galicia. The Sotelo Lab maintains strong industry collaborations with pharmaceutical companies to translate basic research into therapeutic applications. The group operates advanced facilities for combinatorial chemistry, molecular imaging, and 3D-printed catalysis, with particular expertise in developing fluorescent alternatives to radioactive compounds for high-throughput screening. Current work focuses on multi-target immunotherapies and novel catalytic systems for sustainable pharmaceutical manufacturing.